180 Life Sciences Corp. announced the resignation of Dr. James N. Woody as CEO and Director, and Dr. Jonathan Rothbard as Chief Scientific Officer, and the appointment of Mr. Blair Jordan as Interim CEO. Various separation and consulting agreements were entered into with the departing executives.